The immune checkpoint marker programmed death-1 (PD-1) and its ligands programmed death ligand-1 (PD-L1) and programmed death ligand-2 (PD-L2) have attracted interest in the field of cancer immunology owing to conflicting prognostic significance [7]. Here, PDCD1LG2 is linked to cancer.